Estrogen/isoflavone interactions in cynomolgus macaques (Macaca fascicularis)

American Journal of Primatology

Volumn 71, Issue 9, 2009, Pages 722-731

  Cline, J Mark ^a   Wood, Charles E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Breast; Diet; Endometrium; Genistein

Indexed keywords

ESTRADIOL; GENISTEIN; GLYCEOLLIN; PTEROCARPAN DERIVATIVE;

CANCER; EPIDEMIOLOGY; ESTROGENIC COMPOUND; FOOD SUPPLEMENTATION; HEALTH RISK; METABOLISM; PRIMATE; PROTEIN; PUBLIC HEALTH; RODENT;

ANIMAL; BREAST TUMOR; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; DIET; DRUG EFFECT; ENDOMETRIUM TUMOR; FEMALE; HUMAN; MACACA; METABOLISM; REVIEW; SOYBEAN;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; DIET; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; GENISTEIN; HUMANS; MACACA FASCICULARIS; MOLECULAR STRUCTURE; PTEROCARPANS; SOYBEANS;

MACACA; MACACA FASCICULARIS; PRIMATES; RODENTIA;

EID: 69349090531     PISSN: 02752565     EISSN: 10982345     Source Type: Journal    
DOI: 10.1002/ajp.20680     Document Type: Review

References (126)

1. Adams NR. 1995. Organizational and activational effects of phytoestrogens on the reproductive tract of the ewe. Proc Soc Exp Biol Med 208:87-91.
2. Akiyama T, Ishida J, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. 1987. Genistein, a specific inhibitor of tyrosin-specific protein kinases. J Biol Chem 262: 5592-5595.
3. Allred CD, Allred KF, Ju YH, Clausen LM, Doerge DR, Schantz SL, Korol DL, Wallig MA, Helferich WG. 2004. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis 25:211-218.
4. Attia MA. 1998. Cyclic changes in genital organs and vaginal cytology in cynomolgus monkeys (Macaca fascicularis). Dtsch Tierarztl Wochenschr 105:399-404.
5. Barker DJB, editor. 1992. Fetal and infant origins of adult disease. London: BMJ Publishing Group.
6. Barker DJP, Osmond C, Forsen TJ, Kajantie E, Eriksson JG. 2005. Trajectories of growth among children who have coronary events as adults. N Engl J Med 353:1802-1809.
7. Barnes S. 1995. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 125:777S-783S.
8. Bateman HL, Patisaul HB. 2008. Disrupted female reproductive physiology following neonatal exposure to phytoestrogens or estrogen specific ligands is associated with decreased GnRH activation and kisspeptin fiber density in the hypothalamus. Neurotoxicology 29:988-997.
9. Bellino FL, Wise PM. 2003. Nonhuman primate models of menopause workshop. Biol Reprod 68:10-18.
10. Bennetts HW, Underwood EJ, Shier FL. 1946. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust J Agric Res 22:131-138.
11. Beral V. 2003. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427.
12. Boettger-Tong H, Murthy L, Chiappetta C, Kirkland JL, Goodwin B, Adlercreutz H, Stancel GM, Mäkelä S. 1998. A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ Health Perspect 106:369-373.
13. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ. 1995. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87:670-675.
14. Buchler P, Reber HA, Buchler MW, Friess H, Lavey RS, Hines OJ. 2004. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression. Cancer 100:201-210.
15. Burow ME, Boue SM, Collins-Burow BM, Melnik LI, Duong BN, Carter-Wientjes CH, Li S, Wiese TE, Cleveland TE, McLachlan JA. 2001. Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor alpha and beta. J Clin Endocrinol Metab 86:1750-1758.
16. Casanova M, You L, Gaido KW, Archibeque-Engle S, Janszen DB, Heck HA. 1999. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro. Toxicol Sci 51:236-244.
17. Cassidy A, Bingham S, Setchell KD. 1994. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60:333-340.
18. Cline JM. 2007. Assessing the mammary gland of nonhuman primates: effects of endogenous hormones and exogenous hormonal agents and growth factors. Birth Defects Res B Dev Reprod Toxicol 80:126-146.
19. Cline JM, Soderqvist G, von Schoultz E, Skoog L, von Schoultz B. 1996a. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques. Am J Obstet Gynecol 174:93-100.
20. Cline JM, Paschold JC, Anthony MC, Obasanjo IO, Adams MR. 1996b. Effects of hormonal therapies and dietary soy phytoestrogens on vaginal cytology in surgically postmenopausal macaques. Fertil Steril 65:1031-1035.
21. Cline JM, Soderqvist G, Skoog L, von Schoultz B. 1998a. Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques. Breast Cancer Res Treat 48:221-229.
22. Cline JM, Davis VL, Hughes CL. 1998b. Dietary soy has dose- dependent agonist/antagonist effects on the mammary glands and uteri of estrogen-treated rats. Proceedings of the ILSI conference on human diet and endocrine modulation.
23. Cline JM, Register TC, Clarkson TB. 2002. Comparative effects of tibolone and conjugated equine estrogens with and without medroxyprogesterone acetate on the reproductive tract of female cynomolgus monkeys. Menopause 9:242-252.
24. Cline JM, Wood CE, Vidal J, Tarara R, Buse E, Weinbauer G, de Rijk E, van Esch E. 2008. Selected background findings of the female reproductive system in macaques. Toxicol Pathol 36:142S-163S.
25. Constantinou A, Huberman E. 1995. Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc Soc Exp Biol Med 208:109-115.
26. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, Cheng J, Gao YT, Zheng W. 2002. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 11:815-821.
27. Dai Q, Xu WH, Long JR, Courtney R, Xiang YB, Cai Q, Cheng J, Zheng W, Shu XO. 2007. Interaction of soy and 17beta-HSD1 gene polymorphisms in the risk of endometrial cancer. Pharmacogenet Genomics 17: 161-167.
28. Delclos KB, Newbold R. 2007. NTP toxicity report of reproductive dose range-finding study of genistein (CAS No. 446-72-0) administered in feed to Sprague-Dawley rats. Toxic Rep Ser 79:1-C2.
29. Delclos KB, Bucci TJ, Lomax LG, Latendresse JR, Warbritton A, Weis CC, Newbold RR. 2001. Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod Toxicol 15:647-663.
30. den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH. 2001. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 10:223-228.
31. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. 2006. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114:567-572.
32. Dorgan JF, Hunsberger SA, McMahon RP, Kwiterovich PO, Lauer RM, Van Horn L, Lasser LN, Stevens VJ, Friedman LA, Yanovski JA, Greenhut SF, Chandler DW, Franklin FA, Barton BA, Buckman DW, Snetselaar LG, Patterson BH, Schatzkin A, Taylor PR. 2003. Diet and sex hormones in girls: findings from a randomized controlled clinical trial. J Natl Cancer Inst 95:132-141.
33. Duncan AM, Merz-Demlow BE, Xu X, Phipps WR, Kurzer MS. 2000. Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9:581-586.
34. Dunn JE. 1977. Breast cancer among American Japanese in the San Francisco Bay area. Natl Cancer Inst Monogr 47:157-160.
35. Everett JW. 1989. Neurobiology of reproduction in the female rat. A fifty-year perspective. Monogr Endocrinol 32:1-133.
36. Folman Y, Pope GS. 1966. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol 34:215-225.
37. Food and Drug Administration. 1999. Food labeling: health claims; soy protein and coronary heart disease. Fed Regist 64:57699-57733.
38. Foth D, Cline JM. 1998. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr 68:1413S-1417S.
39. Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. 1995. Genistein, a dietary ingested isoflavo noid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 125:790S-797S.
40. Freeman ME. 1994. The neuroendocrine control of the ovarian cycle of the rat. In: Knobil E, Neill JD, editors. The physiology of reproduction, 2nd ed. New York: Raven Press.
41. Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. 1997. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 146:294-306.
42. Greenstein J, Kushi L, Zheng W, Fee R, Campbell D, Sellers T. 1996. Risk of breast cancer associated with intake of specific foods and food groups. Am J Epidemiol 143:S36.
43. Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, Roberts SA, Howell A, Bundred NJ. 1999. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 84: 4017-4024.
44. Hilakivi-Clarke L, Cho E, Cabanes A, DeAssis S, Olivo S, Helferich W, Lippman ME, Clarke R. 2002. Dietary modulation of pregnancy estrogen levels and breast cancer risk among female rat offspring. Clin Cancer Res 8:3601-3610.
45. Hirayama T. 1990. A large scale cohort study on the effect of life styles on the risk of cancer by each site. Gan No Rinsho Spec No: 233-42.
46. Hirose K, Tajima K, Hamajima N, Inoue M, Takezaki T, Kuroishi T, Yoshida M, Tokudome S. 1995. A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res 86:146-154.
47. Hodgen GD, Goodman AL, O'Connor A, Johnson DK. 1977. Menopause in rhesus monkeys: model for study of disorders in the human climacteric. Am J Obstet Gynecol 127:581-584.
48. Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, Sakoda LC, Shiau AC, Goldstein J, Davis P, Perez-Stable EJ. 2001. Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 154:434-441.
49. Horn-Ross PL, Hoggatt KJ, West DW, Krone MR, Stewart SL, Anton H, Bernstein CL, Deapen D, Peel D, Pinder R, Reynolds P, Ross RK, Wright W, Ziogas A. 2002. Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 13:407-415.
50. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. 1998. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58:3833-3838.
51. Imhof M, Molzer S, Imhof M. 2008. Effects of soy isoflavones on 17beta-estradiol-induced proliferation of MCF-7 breast cancer cells. Toxicol In Vitro 22:1452-1460.
52. Ingram D, Sanders K, Kolybaba M, Lopez D. 1997. Case- control study of phyto-oestrogens and breast cancer. Lancet 350:990-994.
53. Kaiserman-Abramof I, Padykula H. 1989. Ultrastructural epithelial zonation of the primate endometrium (rhesus monkey). Am J Anat 184:13-30.
54. Kavanagh K, Koudy Williams J, Wagner JD. 2005. Naturally occurring menopause in cynomolgus monkeys: changes in hormone, lipid, and carbohydrate measures with hormonal status. J Med Primatol 34:171-177.
55. Kelly PA, Binart N, Lucas B, Bouchard B, Goffin V. 2001. Implications of multiple phenotypes observed in prolactin receptor knockout mice. Front Neuroendocrinol 22:140-145.
56. Kiguchi K, Glesne D, Chubb CH, Fujiki H, Huberman E. 1994. Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A. Cell Growth Differ 5:995-1004.
57. Kim MH. 2003. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J Cell Biochem 89:529-538.
58. Kleinberg DL, Niemann W, Flamm E, Cooper P, Babitsky G, Valensi Q. 1985. Primate mammary development. Effects of hypophysectomy, prolactin inhibition, and growth hormone administration. J Clin Invest 75:1943-1950.
59. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:4252-4263.
60. Lamartiniere CA. 2000. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 71: 1705S-1707S; discussion 1708S-1709S.
61. Lamartiniere CA, Murrill WB, Manzolillo PA, Zhang JX, Barnes S, Zhang X, Wei H, Brown NM. 1998. Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc Soc Exp Biol Med 217:358-364.
62. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. 1991. Dietary effects on breast-cancer risk in Singapore. Lancet 337:1197-1200.
63. Li Y, Sarkar FH. 2002. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett 186:157-164.
64. Lu LJ, Anderson KE, Grady JJ, Kohen F, Nagamani M. 2000. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res 60:4112-4121.
65. Lu LJ, Anderson KE, Grady JJ, Nagamani M. 2001. Effects of an isoflavone-free soy diet on ovarian hormones in pre- menopausal women. J Clin Endocrinol Metab 86:3045-3052.
66. Mahoney C. 1970. A study of the menstrual cycle in Macaca irus with special reference to the detection of ovulation. J Reprod Fertil 21:153-163.
67. Martel C, Melner MH, Gagne D, Simard J, Labrie F. 1994. Widespread tissue distribution of steroid sulfatase, 3 beta- hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase 3 beta-HSD, 17 beta-HSD 5 alpha-reductase and aromatase activities in the rhesus monkey. Mol Cell Endocrinol 104:103-111.
68. Martini MC, Dancisak BB, Haggans CJ, Thomas W, Slavin JL. 1999. Effects of soy intake on sex hormone metabolism in premenopausal women. Nutr Cancer 34:133-139.
69. Maskarinec G, Meng L. 2001. An investigation of soy intake and mammographic characteristics in Hawaii. Breast Cancer Res 3:134-141.
70. Maskarinec G, Takata Y, Franke AA, Williams AE, Murphy SP. 2004. A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr 134:3089-3094.
71. McMichael-Phillips DF, Harding C, Morton M, Roberts SA, Howell A, Potten CS, Bundred NJ. 1998. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 68:1431S-1435S.
72. Medina D. 2008. Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens. J Mammary Gland Biol Neoplasia 13:271-277.
73. Messina MJ, Persky V, Setchell KD, Barnes S. 1994. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21:113-131.
74. Miksicek RJ. 1994. Interaction of naturally occurring non- steroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 49:153-160.
75. Morito K, Aomori T, Hirose T, Kinjo J, Hasegawa J, Ogawa S, Inoue S, Muramatsu M, Masamune Y. 2002. Interaction of phytoestrogens with estrogen receptors alpha and beta (II). Biol Pharm Bull 25:48-52.
76. Murray MJ, Meyer WR, Lessey BA, Oi RH, DeWire RE, Fritz MA. 2003. Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial. Menopause 10: 456-464.
77. Myoung H, Hong SP, Yun PY, Lee JH, Kim MJ. 2003. Anti- cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion. Cancer Sci 94:215-220.
78. Nikander E, Rutanen EM, Nieminen P, Wahlström T, Ylikorkala O, Tiitinen A. 2005. Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women. Fertil Steril 83:137-142.
79. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, editors. 1992. IARC scientific publication no. 120; cancer incidence in five continents. Lyon: International Agency for Research on Cancer.
80. Peterson G, Barnes S. 1991. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 179:661-667.
81. Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M, Coward L. 1996. Stimulatory influence of soy protein isolate on breast secretion in pre and postmenopausal women. Cancer Epidemiol Biomarkers Prev 5:785-794.
82. Probst-Hensch NM, Pike MC, McKean-Cowdin R, Stanczyk FZ, Kolonel LN, Henderson BE. 2000. Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight. Br J Cancer 82:1867-1870.
83. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 288:321-333.
84. Sathyamoorthy N, Gilsdorf JS, Wang TT. 1998. Differential effect of genistein on transforming growth factor beta 1 expression in normal and malignant mammary epithelial cells. Anticancer Res 18:2449-2453.
85. Schairer CP, Lubin LP, Troisi RS, Sturgeon SD, Brinton LP, Hoover RMD. 2000. Menopausal estrogen and estrogen- progestin replacement therapy and breast cancer risk. J Am Med Assoc 283:485-491.
86. Scott LM, Xu X, Veenstra TD, Tooze JA, Wood CE, Register TC, Kock ND, Cline JM. 2008. Past oral contraceptive use and current dietary soy isoflavones influence estrogen metabolism in postmenopausal monkeys (Macaca fascicu- laris). Cancer Epidemiol Biomarkers Prev 17:2594-2602.
87. Setchell KD, Gosselin SJ, Welsh MB, Johnston JO, Balistreri WF, Kramer LW, Dresser BL, Tarr MJ. 1987. Dietary estrogens-a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 93:225-233.
88. Sharpe RM, Martin B, Morris K, Greig I, McKinnell C, McNeilly AS, Walker M. 2002. Infant feeding with soy formula milk: effects on the testis and on blood testosterone levels in marmoset monkeys during the period of neonatal testicular activity. Hum Reprod 17:1692-1703.
89. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. 1991. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63:963-966.
90. Shu XO, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, Ruan Z, Gao YT, Zheng W. 2001. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10:483-488.
91. Simon NG, Kaplan JR, Hu S, Register TC, Adams MR. 2004. Increased aggressive behavior and decreased affiliative behavior in adult male monkeys after long-term consumption of diets rich in soy protein and isoflavones. Horm Behav 45:278-284.
92. Söderqvist G, Olsson H, Wilking N, von Schoultz B, Carlstrom K. 1994. Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives. J Steroid Biochem Mol Biol 48:221-224.
93. Söderqvist G, Poutanen M, Wickman M, von Schoultz B, Skoog L, Vihko R. 1998. 17Beta-hydroxysteroid dehydrogenase type 1 in normal breast tissue during the menstrual cycle and hormonal contraception. J Clin Endocrinol Metab 83:1190-1193.
94. Soyatech Inc. 2008. U.S. retail sales of soy foods 1992-2002. Available from: http://www.fda.gov/fdac/features/2000/soychart.html. 2003. Food and Drug Administration. Accessed on 10/19/2008.
95. Soy Foods Association of North America. 2008. Soyfood sales & trends. Availabe from: http://www.soyfoods.org/products/sales-and-trends/. Accessed on 10/19/2008.
96. Speert H. 1948. The normal and experimental development of the mammary gland of the rhesus monkey with some pathologic correlations. Contrib Embryol (Carnegie Inst Wash) 32:9-65.
97. Stanford JL, Herrinton LJ, Schwartz SM, Weiss NS. 1995. Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology 6:181-183.
98. Stroud FC, Appt SE, Wilson ME, Franke AA, Adams MR, Kaplan JR. 2006. Concentrations of isoflavones in macaques consuming standard laboratory monkey diet. J Am Assoc Lab Anim Sci 45:20-23.
99. Tanos V, Brzezinski A, Drize O, Strauss N, Peretz T. 2002. Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. Eur J Obstet Gynecol Reprod Biol 102:188-194.
100. Thigpen JE, Setchell KD, Ahlmark KB, Locklear J, Spahr T, Caviness GF, Goelz MF, Haseman JK, Newbold RR, Forsythe DB. 1999. Phytoestrogen content of purified, open and closed-formula laboratory animal diets. Lab Anim Sci 49:530-536.
101. Trock BJ, Hilakivi-Clarke L, Clarke R. 2006. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98:459-471.
102. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. 2004. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril 82:145-148.
103. Wang TT, Sathyamoorthy N, Phang JM. 1996. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17:271-275.
104. Warri A, Saarinen NM, Makela S, Hilakivi-Clarke L. 2008. The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer 98:1485-1493.
105. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. 1995. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208:124-130.
106. Weinbauer GF, Niehoff M, Niehaus M, Srivastav S, Fuchs A, van Esch E, Cline JM. 2008. Physiology and endocrinology of the ovarian cycle in macaques. Toxicol Pathol 36:7S-23S.
107. Westwood FR. 2008. The female rat reproductive cycle: a practical histological guide to staging. Toxicol Pathol 36:375-384.
108. Wietrzyk J, Grynkiewicz G, Opolski A. 2005. Phytoestrogens in cancer prevention and therapy-mechanisms of their biological activity. Anticancer Res 25:2357-2366.
109. Witte JS, Ursin G, Siemiatycki J, Thompson WD, Paganini- Hill A, Haile RW. 1997. Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Res Treat 42:243-251.
110. Wood CE, Messina MJ. 2008. Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J 7:17.
111. Wood CE, Barnes S, Cline JM. 2002. Phytoestrogens and health: cancer: effects on the breast and uterus. In: Gilani GS, Anderson JJB, editors. Phytoestrogens and health. Champaign, IL: American Oil Chemist's Society Press. p 440-469.
112. Wood CE, Register TC, Anthony MS, Kock ND, Cline JM. 2004. Breast and uterine effects of soy isoflavones and conjugated equine estrogens in postmenopausal female monkeys. J Clin Endocrinol Metab 89:3462-3468.
113. Wood CE, Usborne AL, Starost MF, Tarara RP, Hill LR, Wilkinson LM, Geisinger KR, Feiste EA, Cline JM. 2006a. Hyperplastic and neoplastic lesions of the mammary gland in macaques. Vet Pathol 43:471-483.
114. Wood CE, Register TC, Franke AA, Anthony MS, Cline JM. 2006b. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res 66: 1241-1249.
115. Wood CE, Appt SE, Clarkson TB, Franke AA, Lees CJ, Doerge DR, Cline JM. 2006c. Effects of high-dose soy isoflavones and equol on reproductive tissues in female cynomolgus monkeys. Biol Reprod 75:477-486.
116. Wood CE, Clarkson TB, Appt SE, Franke AA, Boue SM, Burow ME, McCoy T, Cline JM. 2006d. Effects of soybean glyceollins and estradiol in postmenopausal female mon- keys. Nutr Cancer 56:74-81.
117. Wood CE, Register TC, Cline JM. 2007. Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys. Carcinogenesis 4:801-808.
118. Wu AH, Ziegler RG, Horn-Ross PL, Nomura AM, West DW, Kolonel LN, Rosenthal JF, Hoover RN, Pike MC. 1996. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 5:901-906.
119. Wu AH, Ziegler RG, Nomura AM, West DW, Kolonel LN, Horn-Ross PL, Hoover RN, Pike MC. 1998. Soy intake and risk of breast cancer in Asians and Asian Americans. Am J Clin Nutr 68:1437S-1443S.
120. Wu AH, Stanczyk FZ, Hendrich S, Murphy PA, Zhang C, Wan P, Pike MC. 2000. Effects of soy foods on ovarian function in premenopausal women. Br J Cancer 82: 1879-1886.
121. Wu AH, Stanczyk FZ, Seow A, Lee HP, Yu MC. 2002a. Soy intake and other lifestyle determinants of serum estrogen levels among postmenopausal Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 11:844-851.
122. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. 2002b. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23:1491-1496.
123. Xu X, Duncan AM, Wangen KE, Kurzer MS. 2000. Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev 9:781-786.
124. Yuan JM, Wang QS, Ross RK, Henderson BE, Yu MC. 1995. Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 71:1353-1358.
125. Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, Jin F, Franke AA. 1999. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8:35-40.
126. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB. 1993. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819-1827.